Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Concentration-response curves and non-monotonic patterns

Interpret rising, falling and turning assay responses without forcing every dataset into a single sigmoid or inferring an optimal human dose.

A concentration-response plot asks how a measured endpoint varies across tested concentrations. Some patterns rise towards a plateau; others turn upwards or downwards within the observed range. A turning pattern can be informative, but its shape alone does not establish why it occurs. Description, curve fitting and mechanism are separate stages of interpretation.

Describe the observed direction before naming a mechanism

Monotonic means the response proceeds in one direction across the range, allowing plateaus. A non-monotonic pattern changes direction, as in a rise followed by a fall. These are descriptions of a relationship rather than explanations of its cause.

Record the endpoint and its orientation. A falling viability signal and a rising inhibition percentage can describe the same underlying change after transformation, so the vertical-axis label matters.

Also distinguish the tested range from a complete response curve. Data observed only on a rising segment do not establish whether a later plateau or reversal would occur.

For a peptide study, retain the concentration basis and exposure time. A nominal concentration-response relationship does not establish that unbound intact peptide increased proportionally at every point.

Check whether the observations support a turn

Original hypothetical concentration series
Concentration unitsMean response units
110
335
1070
3040
10015

The fictional means rise and then fall, with the largest observed mean at 10 concentration units. The table contains no replicate values or uncertainty estimates, so it cannot establish how reliably the turning pattern would repeat.

It also cannot locate the exact peak between sampled concentrations. Calling 10 the best concentration would add a judgement about objectives, other outcomes and unmeasured values that the table does not supply.

If the final two points were omitted, the visible series would look like a simple rise. Selective presentation of the concentration range can therefore change the apparent story.

When reading the full figure, inspect how many observations support each side of the turn and whether the pattern depends on one unusual measurement.

Treat a fitted curve as a model with assumptions

GraphPad’s official bell-shaped model combines rising and falling components and warns that many observations are needed to estimate its parameters reliably. A smooth fitted line can therefore be easier to obtain than a well-determined interpretation of every fitted parameter.GraphPad — Equation: Bell-shaped dose-response (opens in a new tab)

Ask whether the chosen equation can represent the actual pattern and whether parameter uncertainty is reported. A single standard sigmoid may conceal a turn instead of explaining it.

Conversely, a flexible equation can follow sparse points without demonstrating two biological pathways. Mathematical components do not automatically correspond to identified receptors or mechanisms.

Look for evidence that distinguishes possible causes

Owen and colleagues found that colloidal formulations of selected drugs produced bell-shaped concentration-response curves while monomeric formulations behaved differently. Their original study establishes a physical explanation for some cases, explicitly not a universal explanation for all turning curves.Owen and colleagues — Colloidal drug formulations can explain bell-shaped concentration-response curves (opens in a new tab)

In another experiment, the explanation must be assessed from its own evidence. Potential changes in material state, detection behaviour or the biological system should not be assigned solely from visual resemblance to a published curve.

A useful summary reports the supported concentration range, endpoint, turning pattern and uncertainty about cause. If follow-up experiments identify a mechanism, explain their contribution separately from the original fit.

Laboratory concentrations describe the tested system. They do not by themselves establish exposure, benefit or safety in people, and the position of an assay peak is not a human dosing recommendation.

Sources and further detail

  1. GraphPad — Equation: Bell-shaped dose-response (opens in a new tab)

    Official model introduction and parameter explanation read. Brief note on model complexity and estimation limits; no software-version claim or copied fitting workflow.

  2. Owen and colleagues — Colloidal drug formulations can explain bell-shaped concentration-response curves (opens in a new tab)

    Original 2014 abstract and indexed PMC conclusion read. Short formulation-specific example; no claim that all non-monotonic responses involve aggregation. Concentration table and interpretation are original.

Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.